Treatment interventions to maintain abstinence from alcohol in primary care: systematic review and network meta-analysis
AbstractObjectiveTo determine the most effective interventions in recently detoxified, alcohol dependent patients for implementation in primary care.DesignSystematic review and network meta-analysis.Data sourcesMedline, Embase, PsycINFO, Cochrane CENTRAL, ClinicalTrials.gov, and the World Health Org...
Saved in:
| Published in: | BMJ (Online) Vol. 371; p. m3934 |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
England
British Medical Journal Publishing Group
25.11.2020
BMJ Publishing Group LTD BMJ Publishing Group Ltd |
| Subjects: | |
| ISSN: | 1756-1833, 0959-8138, 1756-1833 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | AbstractObjectiveTo determine the most effective interventions in recently detoxified, alcohol dependent patients for implementation in primary care.DesignSystematic review and network meta-analysis.Data sourcesMedline, Embase, PsycINFO, Cochrane CENTRAL, ClinicalTrials.gov, and the World Health Organization’s International Clinical Trials Registry Platform.Study selectionRandomised controlled trials comparing two or more interventions that could be used in primary care. The population was patients with alcohol dependency diagnosed by standardised clinical tools and who became detoxified within four weeks.Data extractionOutcomes of interest were continuous abstinence from alcohol (effectiveness) and all cause dropouts (as a proxy for acceptability) at least 12 weeks after start of intervention.Results64 trials (43 interventions) were included. The median probability of abstinence across placebo arms was 25%. Compared with placebo, the only intervention associated with increased probability of abstinence and moderate certainty evidence was acamprosate (odds ratio 1.86, 95% confidence interval 1.49 to 2.33, corresponding to an absolute probability of 38%). Of the 62 included trials that reported all cause dropouts, interventions associated with a reduced number of dropouts compared with placebo (probability 50%) and moderate certainty of evidence were acamprosate (0.73, 0.62 to 0.86; 42%), naltrexone (0.70, 0.50 to 0.98; 41%), and acamprosate-naltrexone (0.30, 0.13 to 0.67; 17%). Acamprosate was the only intervention associated with moderate confidence in the evidence of effectiveness and acceptability up to 12 months. It is uncertain whether other interventions can help maintain abstinence and reduce dropouts because of low confidence in the evidence.ConclusionsEvidence is lacking for benefit from interventions that could be implemented in primary care settings for alcohol abstinence, other than for acamprosate. More evidence from high quality randomised controlled trials is needed, as are strategies using combined interventions (combinations of drug interventions or drug and psychosocial interventions) to improve treatment of alcohol dependency in primary care.Systematic review registrationPROSPERO CRD42016049779. |
|---|---|
| AbstractList | To determine the most effective interventions in recently detoxified, alcohol dependent patients for implementation in primary care.
Systematic review and network meta-analysis.
Medline, Embase, PsycINFO, Cochrane CENTRAL, ClinicalTrials.gov, and the World Health Organization's International Clinical Trials Registry Platform.
Randomised controlled trials comparing two or more interventions that could be used in primary care. The population was patients with alcohol dependency diagnosed by standardised clinical tools and who became detoxified within four weeks.
Outcomes of interest were continuous abstinence from alcohol (effectiveness) and all cause dropouts (as a proxy for acceptability) at least 12 weeks after start of intervention.
64 trials (43 interventions) were included. The median probability of abstinence across placebo arms was 25%. Compared with placebo, the only intervention associated with increased probability of abstinence and moderate certainty evidence was acamprosate (odds ratio 1.86, 95% confidence interval 1.49 to 2.33, corresponding to an absolute probability of 38%). Of the 62 included trials that reported all cause dropouts, interventions associated with a reduced number of dropouts compared with placebo (probability 50%) and moderate certainty of evidence were acamprosate (0.73, 0.62 to 0.86; 42%), naltrexone (0.70, 0.50 to 0.98; 41%), and acamprosate-naltrexone (0.30, 0.13 to 0.67; 17%). Acamprosate was the only intervention associated with moderate confidence in the evidence of effectiveness and acceptability up to 12 months. It is uncertain whether other interventions can help maintain abstinence and reduce dropouts because of low confidence in the evidence.
Evidence is lacking for benefit from interventions that could be implemented in primary care settings for alcohol abstinence, other than for acamprosate. More evidence from high quality randomised controlled trials is needed, as are strategies using combined interventions (combinations of drug interventions or drug and psychosocial interventions) to improve treatment of alcohol dependency in primary care.
PROSPERO CRD42016049779. ObjectiveTo determine the most effective interventions in recently detoxified, alcohol dependent patients for implementation in primary care.DesignSystematic review and network meta-analysis.Data sourcesMedline, Embase, PsycINFO, Cochrane CENTRAL, ClinicalTrials.gov, and the World Health Organization’s International Clinical Trials Registry Platform.Study selectionRandomised controlled trials comparing two or more interventions that could be used in primary care. The population was patients with alcohol dependency diagnosed by standardised clinical tools and who became detoxified within four weeks.Data extractionOutcomes of interest were continuous abstinence from alcohol (effectiveness) and all cause dropouts (as a proxy for acceptability) at least 12 weeks after start of intervention.Results64 trials (43 interventions) were included. The median probability of abstinence across placebo arms was 25%. Compared with placebo, the only intervention associated with increased probability of abstinence and moderate certainty evidence was acamprosate (odds ratio 1.86, 95% confidence interval 1.49 to 2.33, corresponding to an absolute probability of 38%). Of the 62 included trials that reported all cause dropouts, interventions associated with a reduced number of dropouts compared with placebo (probability 50%) and moderate certainty of evidence were acamprosate (0.73, 0.62 to 0.86; 42%), naltrexone (0.70, 0.50 to 0.98; 41%), and acamprosate-naltrexone (0.30, 0.13 to 0.67; 17%). Acamprosate was the only intervention associated with moderate confidence in the evidence of effectiveness and acceptability up to 12 months. It is uncertain whether other interventions can help maintain abstinence and reduce dropouts because of low confidence in the evidence.ConclusionsEvidence is lacking for benefit from interventions that could be implemented in primary care settings for alcohol abstinence, other than for acamprosate. More evidence from high quality randomised controlled trials is needed, as are strategies using combined interventions (combinations of drug interventions or drug and psychosocial interventions) to improve treatment of alcohol dependency in primary care.Systematic review registrationPROSPERO CRD42016049779. AbstractObjectiveTo determine the most effective interventions in recently detoxified, alcohol dependent patients for implementation in primary care.DesignSystematic review and network meta-analysis.Data sourcesMedline, Embase, PsycINFO, Cochrane CENTRAL, ClinicalTrials.gov, and the World Health Organization’s International Clinical Trials Registry Platform.Study selectionRandomised controlled trials comparing two or more interventions that could be used in primary care. The population was patients with alcohol dependency diagnosed by standardised clinical tools and who became detoxified within four weeks.Data extractionOutcomes of interest were continuous abstinence from alcohol (effectiveness) and all cause dropouts (as a proxy for acceptability) at least 12 weeks after start of intervention.Results64 trials (43 interventions) were included. The median probability of abstinence across placebo arms was 25%. Compared with placebo, the only intervention associated with increased probability of abstinence and moderate certainty evidence was acamprosate (odds ratio 1.86, 95% confidence interval 1.49 to 2.33, corresponding to an absolute probability of 38%). Of the 62 included trials that reported all cause dropouts, interventions associated with a reduced number of dropouts compared with placebo (probability 50%) and moderate certainty of evidence were acamprosate (0.73, 0.62 to 0.86; 42%), naltrexone (0.70, 0.50 to 0.98; 41%), and acamprosate-naltrexone (0.30, 0.13 to 0.67; 17%). Acamprosate was the only intervention associated with moderate confidence in the evidence of effectiveness and acceptability up to 12 months. It is uncertain whether other interventions can help maintain abstinence and reduce dropouts because of low confidence in the evidence.ConclusionsEvidence is lacking for benefit from interventions that could be implemented in primary care settings for alcohol abstinence, other than for acamprosate. More evidence from high quality randomised controlled trials is needed, as are strategies using combined interventions (combinations of drug interventions or drug and psychosocial interventions) to improve treatment of alcohol dependency in primary care.Systematic review registrationPROSPERO CRD42016049779. To determine the most effective interventions in recently detoxified, alcohol dependent patients for implementation in primary care.OBJECTIVETo determine the most effective interventions in recently detoxified, alcohol dependent patients for implementation in primary care.Systematic review and network meta-analysis.DESIGNSystematic review and network meta-analysis.Medline, Embase, PsycINFO, Cochrane CENTRAL, ClinicalTrials.gov, and the World Health Organization's International Clinical Trials Registry Platform.DATA SOURCESMedline, Embase, PsycINFO, Cochrane CENTRAL, ClinicalTrials.gov, and the World Health Organization's International Clinical Trials Registry Platform.Randomised controlled trials comparing two or more interventions that could be used in primary care. The population was patients with alcohol dependency diagnosed by standardised clinical tools and who became detoxified within four weeks.STUDY SELECTIONRandomised controlled trials comparing two or more interventions that could be used in primary care. The population was patients with alcohol dependency diagnosed by standardised clinical tools and who became detoxified within four weeks.Outcomes of interest were continuous abstinence from alcohol (effectiveness) and all cause dropouts (as a proxy for acceptability) at least 12 weeks after start of intervention.DATA EXTRACTIONOutcomes of interest were continuous abstinence from alcohol (effectiveness) and all cause dropouts (as a proxy for acceptability) at least 12 weeks after start of intervention.64 trials (43 interventions) were included. The median probability of abstinence across placebo arms was 25%. Compared with placebo, the only intervention associated with increased probability of abstinence and moderate certainty evidence was acamprosate (odds ratio 1.86, 95% confidence interval 1.49 to 2.33, corresponding to an absolute probability of 38%). Of the 62 included trials that reported all cause dropouts, interventions associated with a reduced number of dropouts compared with placebo (probability 50%) and moderate certainty of evidence were acamprosate (0.73, 0.62 to 0.86; 42%), naltrexone (0.70, 0.50 to 0.98; 41%), and acamprosate-naltrexone (0.30, 0.13 to 0.67; 17%). Acamprosate was the only intervention associated with moderate confidence in the evidence of effectiveness and acceptability up to 12 months. It is uncertain whether other interventions can help maintain abstinence and reduce dropouts because of low confidence in the evidence.RESULTS64 trials (43 interventions) were included. The median probability of abstinence across placebo arms was 25%. Compared with placebo, the only intervention associated with increased probability of abstinence and moderate certainty evidence was acamprosate (odds ratio 1.86, 95% confidence interval 1.49 to 2.33, corresponding to an absolute probability of 38%). Of the 62 included trials that reported all cause dropouts, interventions associated with a reduced number of dropouts compared with placebo (probability 50%) and moderate certainty of evidence were acamprosate (0.73, 0.62 to 0.86; 42%), naltrexone (0.70, 0.50 to 0.98; 41%), and acamprosate-naltrexone (0.30, 0.13 to 0.67; 17%). Acamprosate was the only intervention associated with moderate confidence in the evidence of effectiveness and acceptability up to 12 months. It is uncertain whether other interventions can help maintain abstinence and reduce dropouts because of low confidence in the evidence.Evidence is lacking for benefit from interventions that could be implemented in primary care settings for alcohol abstinence, other than for acamprosate. More evidence from high quality randomised controlled trials is needed, as are strategies using combined interventions (combinations of drug interventions or drug and psychosocial interventions) to improve treatment of alcohol dependency in primary care.CONCLUSIONSEvidence is lacking for benefit from interventions that could be implemented in primary care settings for alcohol abstinence, other than for acamprosate. More evidence from high quality randomised controlled trials is needed, as are strategies using combined interventions (combinations of drug interventions or drug and psychosocial interventions) to improve treatment of alcohol dependency in primary care.PROSPERO CRD42016049779.SYSTEMATIC REVIEW REGISTRATIONPROSPERO CRD42016049779. |
| Author | Lingford-Hughes, Anne López-López, José A Cowlishaw, Sean Elbers, Roy G Hickman, Matthew McAleenan, Alexandra Kessler, David Cheng, Hung-Yuan McGuinness, Luke A Taylor, Abigail Higgins, Julian P T MacArthur, Georgina J Dawson, Sarah |
| Author_xml | – sequence: 1 givenname: Hung-Yuan surname: Cheng fullname: Cheng, Hung-Yuan organization: Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK – sequence: 2 givenname: Luke A surname: McGuinness fullname: McGuinness, Luke A organization: Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK – sequence: 3 givenname: Roy G surname: Elbers fullname: Elbers, Roy G organization: Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK – sequence: 4 givenname: Georgina J surname: MacArthur fullname: MacArthur, Georgina J organization: Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK – sequence: 5 givenname: Abigail surname: Taylor fullname: Taylor, Abigail organization: Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK – sequence: 6 givenname: Alexandra surname: McAleenan fullname: McAleenan, Alexandra organization: Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK – sequence: 7 givenname: Sarah surname: Dawson fullname: Dawson, Sarah organization: Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK – sequence: 8 givenname: José A surname: López-López fullname: López-López, José A organization: Department of Basic Psychology and Methodology, University of Murcia, Spain – sequence: 9 givenname: Julian P T surname: Higgins fullname: Higgins, Julian P T organization: National Institute for Health Research Bristol Biomedical Research Centre, University Hospitals Bristol NHS Foundation Trust and University of Bristol, Bristol, UK – sequence: 10 givenname: Sean surname: Cowlishaw fullname: Cowlishaw, Sean organization: Department of Psychiatry, University of Melbourne, Melbourne, Victoria, Australia – sequence: 11 givenname: Anne surname: Lingford-Hughes fullname: Lingford-Hughes, Anne organization: Faculty of Medicine, Department of Brain Sciences, Imperial College London, London, UK – sequence: 12 givenname: Matthew surname: Hickman fullname: Hickman, Matthew organization: National Institute for Health Research Bristol Biomedical Research Centre, University Hospitals Bristol NHS Foundation Trust and University of Bristol, Bristol, UK – sequence: 13 givenname: David orcidid: 0000-0001-5333-132X surname: Kessler fullname: Kessler, David email: david.kessler@bristol.ac.uk organization: National Institute for Health Research School for Primary Care Research, University of Bristol, Bristol, UK |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33239318$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kU1rVDEYhYNUbK1d-AckoIIubpuPe5OMC0GKX1BwU9chN_PGZrxJapKZOv_ejDOOtYqLkPDmOYf3cB6ig5giIPSYklNKuTgbw-I08Bnv76EjKgfRUcX5wa33ITopZUEIYVyqmRgeoEPOWVNQdYS-X2YwNUCs2McKedVePsWCa8LBtFE72Iyl-gjRAnY5BWwmm67S1BT4Ovtg8hpbk-EVLutSIZjqLc6w8nCDTZzjCPUm5a84QDWdiWZaF18eofvOTAVOdvcx-vzu7eX5h-7i0_uP528uurEXrHaOslEOcj5aRpSQlClhqRVOWi6YA2WsE0Zax9VgnXWkd1QAs73slZFgHD9Gr7e-18sxwNy2fNlMere3TsbrP3-iv9Jf0kpLoSRhtBm82Bnk9G0Jpergi4VpMhHSsmjWi14QRfpZQ5_eQRdpmVvgLcUJE2xo1JPbG-1X-VVKA15uAZtTKRncHqFEbzrXrXP9s_PGnt1hra9mU2EL46d_Kp5tFZvR_4yf_8b2Mf7mfgAeC8pp |
| CitedBy_id | crossref_primary_10_1080_10550887_2023_2257106 crossref_primary_10_3390_ijerph20156514 crossref_primary_10_1111_ajad_13431 crossref_primary_10_1177_02537176241245083 crossref_primary_10_1007_s11920_024_01567_4 crossref_primary_10_1093_alcalc_agac070 crossref_primary_10_1055_a_1513_9420 crossref_primary_10_7326_M23_1419 crossref_primary_10_1111_apt_17665 crossref_primary_10_1111_acps_13802 crossref_primary_10_1016_j_jpsychires_2023_06_042 crossref_primary_10_1177_17557380211053031 crossref_primary_10_1111_add_16391 crossref_primary_10_1136_bmj_m4129 crossref_primary_10_1111_acem_14911 crossref_primary_10_1155_2022_7062105 crossref_primary_10_3390_ijerph18136923 crossref_primary_10_4331_wjbc_v12_i5_87 crossref_primary_10_1093_alcalc_agac043 crossref_primary_10_1016_j_addbeh_2024_108242 crossref_primary_10_1002_jhm_70033 crossref_primary_10_1038_s41386_021_01097_0 crossref_primary_10_1111_bph_15795 crossref_primary_10_3389_fpubh_2023_1110435 crossref_primary_10_1007_s00115_022_01385_0 crossref_primary_10_34133_jemdr_0001 crossref_primary_10_1016_j_phrs_2022_106204 crossref_primary_10_1136_bmj_n5 crossref_primary_10_1007_s15202_023_5631_7 crossref_primary_10_1080_14728214_2024_2342951 crossref_primary_10_56083_RCV5N2_085 |
| Cites_doi | 10.1111/j.1530-0277.2007.00536.x 10.1186/1748-5908-8-49 10.1016/S0306-4603(99)00065-9 10.1046/j.1360-0443.2002.00019.x 10.1002/14651858.CD001867.pub2 10.1097/00019442-200506000-00008 10.1186/s13643-017-0462-2 10.1371/journal.pone.0099682 10.1093/alcalc/agq077 10.1001/archpsyc.1997.01830200024004 10.7326/M14-2385 10.1371/journal.pone.0087366 10.15288/jsa.1998.59.631 10.1016/j.clinthera.2005.06.015 10.1002/jrsm.1044 10.1002/sim.3767 10.1034/j.1600-0447.2002.02332.x 10.1177/0269881112444324 10.1016/j.phrs.2008.03.001 10.1002/lary.25688 10.1136/bmj.38636.593461.68 10.1371/journal.pone.0076654 10.1111/add.13974 10.1001/jamapsychiatry.2013.4642 10.1186/s12913-017-2031-8 10.1097/01.ALC.0000108656.81563.05 10.1111/j.1530-0277.2008.00742.x 10.14748/bmr.v30.6393 10.1136/bmj.l4898 10.1111/j.1600-0447.2001.00150.x 10.1136/bmj.39469.432118.AD 10.1001/jama.1986.03380110055026 10.1093/alcalc/agh136 10.1016/j.jsat.2014.11.009 10.1080/10550490701375558 10.1609/icwsm.v3i1.13937 10.1002/14651858.CD004332.pub2 10.1111/add.12875 10.1097/ADT.0b013e318196d4e5 10.1007/978-1-4612-2878-3_44 10.1136/bmj.331.7516.541 10.1093/alcalc/agz106 10.1093/alcalc/agq005 10.1371/journal.pmed.1003082 10.1093/alcalc/36.5.413 10.1016/S0140-6736(14)61838-9 10.7759/cureus.3107 10.1111/j.1360-0443.2006.01433.x 10.4088/JCP.v65n1017 10.1002/cl2.1080 |
| ContentType | Journal Article |
| Copyright | Author(s) (or their employer(s)) 2019. Re-use permitted under CC
BY. No commercial re-use. See rights and permissions. Published by
BMJ. Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ. 2020 Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ. BMJ http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ. 2020 BMJ |
| Copyright_xml | – notice: Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ. – notice: Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ. – notice: 2020 Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ. BMJ http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ. 2020 BMJ |
| DBID | 9YT ACMMV AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7RV 7X7 7XB 88I 8AF 8FE 8FH 8FI 8FJ 8FK 8G5 ABUWG AFKRA AN0 ASE AZQEC BBNVY BENPR BHPHI BTHHO CCPQU DWQXO FPQ FYUFA GHDGH GNUQQ GUQSH HCIFZ K6X K9. KB0 LK8 M2O M2P M7P MBDVC NAPCQ PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS Q9U 7X8 5PM |
| DOI | 10.1136/bmj.m3934 |
| DatabaseName | BMJ Open Access Journals BMJ Journals:Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Nursing & Allied Health Database Health & Medical Collection (ProQuest) ProQuest Central (purchase pre-March 2016) Science Database (Alumni Edition) STEM Database ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Research Library (Alumni) ProQuest Central (Alumni) ProQuest Central UK/Ireland British Nursing Database British Nursing Index ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection BMJ Journals ProQuest One ProQuest Central Korea British Nursing Index (BNI) (1985 to Present) Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Research Library SciTech Premium Collection British Nursing Index ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Biological Sciences Research Library Science Database (ProQuest) Biological Science Database Research Library (Corporate) Nursing & Allied Health Premium Proquest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Research Library Prep ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest AP Science ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Natural Science Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Research Library ProQuest Central (New) ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition British Nursing Index with Full Text British Nursing Index ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition BMJ Journals ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE Research Library Prep MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1756-1833 |
| ExternalDocumentID | PMC7687021 33239318 10_1136_bmj_m3934 bmj |
| Genre | Network Meta-Analysis Research Support, Non-U.S. Gov't Systematic Review Journal Article |
| GeographicLocations | United Kingdom--UK |
| GeographicLocations_xml | – name: United Kingdom--UK |
| GrantInformation_xml | – fundername: Department of Health grantid: DRF-2018-11-ST2-048 – fundername: Medical Research Council grantid: MR/N00616X/1 |
| GroupedDBID | 23N 39C 4.4 40O 53G 5GY 7RV 7X7 88I 8AF 8F7 8FE 8FH 8FI 8FJ 8G5 9YT AACGO AANCE AAWJN ABBHK ABIVO ABJNI ABPLY ABTLG ABUWG ABVAJ ABXSQ ACGFS ACGOD ACMFJ ACMMV ACPRK AEUPB AEXZC AFKRA AGFXO AHMBA AHNKE AHQMW AJYBZ ALIPV ALMA_UNASSIGNED_HOLDINGS AZQEC BBNVY BENPR BHPHI BPHCQ BTHHO C45 CCPQU CS3 DCCCD DWQXO EBS EJD F5P FYUFA GNUQQ GUQSH H13 HAJ HCIFZ HMCUK HZ~ IPSME JAAYA JBMMH JENOY JHFFW JKQEH JLS JLXEF JPM JSG JST L7B LK8 M2O M2P M7P NAPCQ NXWIF O9- OVD PHGZT PQQKQ PROAC R53 RHI RMJ RV8 SA0 TEORI UKHRP VVN WOQ YFH YQY AAYXX AFFHD AN0 CITATION IAG IBB IMI PHGZM PJZUB PPXIY PQGLB CGR CUY CVF ECM EIF NPM 3V. 7XB 8FK ASE FPQ K6X K9. MBDVC PKEHL PQEST PQUKI PRINS PUEGO Q9U 7X8 5PM |
| ID | FETCH-LOGICAL-b462t-f12b757dbc208671286c1c6f7c362fe8acf6a7cf385cfcf04f16e2c4748a7eaf3 |
| IEDL.DBID | M2P |
| ISICitedReferencesCount | 45 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000595061600017&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1756-1833 0959-8138 |
| IngestDate | Tue Nov 04 01:54:39 EST 2025 Sat Sep 27 19:43:41 EDT 2025 Mon Sep 08 13:52:30 EDT 2025 Mon Jul 21 06:02:07 EDT 2025 Tue Nov 18 22:24:09 EST 2025 Sat Nov 29 04:10:43 EST 2025 Thu Apr 24 23:09:47 EDT 2025 Thu Apr 24 22:50:29 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Language | English |
| License | This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/. Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-b462t-f12b757dbc208671286c1c6f7c362fe8acf6a7cf385cfcf04f16e2c4748a7eaf3 |
| Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 content type line 14 ObjectType-Feature-3 ObjectType-Evidence Based Healthcare-1 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 |
| ORCID | 0000-0001-5333-132X |
| OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC7687021 |
| PMID | 33239318 |
| PQID | 2464302625 |
| PQPubID | 2043523 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_7687021 proquest_miscellaneous_2464608049 proquest_journals_2464302625 pubmed_primary_33239318 crossref_primary_10_1136_bmj_m3934 crossref_citationtrail_10_1136_bmj_m3934 bmj_primary_10_1136_bmj_m3934 bmj_journals_10_1136_bmj_m3934 |
| PublicationCentury | 2000 |
| PublicationDate | 20201125 2020-11-25 |
| PublicationDateYYYYMMDD | 2020-11-25 |
| PublicationDate_xml | – month: 11 year: 2020 text: 20201125 day: 25 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: London |
| PublicationTitle | BMJ (Online) |
| PublicationTitleAbbrev | BMJ |
| PublicationTitleAlternate | BMJ |
| PublicationYear | 2020 |
| Publisher | British Medical Journal Publishing Group BMJ Publishing Group LTD BMJ Publishing Group Ltd |
| Publisher_xml | – name: British Medical Journal Publishing Group – name: BMJ Publishing Group LTD – name: BMJ Publishing Group Ltd |
| References | Williams, Aspinall, Bellis (ref2) 2014; 384 (ref12) 2005; 331 Ahmed, Kotapati, Khan (ref47) 2018; 10 Hutton, Salanti, Caldwell (ref11) 2015; 162 Fuller, Branchey, Brightwell (ref23) 1986; 256 Lejoyeux, Lehert (ref55) 2011; 46 Moraes, de Campos, Figlie, Ferraz, Laranjeira (ref43) 2010; 9 Donoghue, Elzerbi, Saunders, Whittington, Pilling, Drummond (ref48) 2015; 110 Jirapramukpitak, Pattanaseri, Chua, Takizawa (ref42) 2020; 55 Adamson, Heather, Morton, Raistrick (ref13) 2010; 45 Greenhalgh, Peacock (ref15) 2005; 331 Harrison, Graham, van den Hoek, Dogherty, Carley, Angus (ref53) 2013; 8 Wetzel, Szegedi, Scheurich (ref45) 2004; 65 Dawson, Goldstein, Grant (ref14) 2007; 31 Rösner, Hackl-Herrwerth, Leucht, Vecchi, Srisurapanont, Soyka (ref49) 2010 Palpacuer, Duprez, Huneau (ref46) 2018; 113 Salanti, Del Giovane, Chaimani, Caldwell, Higgins (ref21) 2014; 9 Dawson, Grant, Stinson, Chou (ref5) 2006; 101 Gustafson, McTavish, Chih (ref37) 2014; 71 (ref40) 1998; 59 Skinner, Lahmek, Pham, Aubin (ref51) 2014; 9 Mann, Lehert, Morgan (ref17) 2004; 28 Dias, Welton, Caldwell, Ades (ref27) 2010; 29 Burtscheidt, Wölwer, Schwarz (ref39) 2001; 103 Higgins, Jackson, Barrett, Lu, Ades, White (ref26) 2012; 3 Liu, Wang, Zhang, Bai, Zhang (ref28) 2016; 126 Cornelius, Salloum, Haskett (ref33) 2000; 25 Sekhon, Cartwright, Francis (ref52) 2017; 17 Sterne, Savović, Page (ref18) 2019; 366 Gillam (ref8) 2008; 336 Gual, Lehert (ref31) 2001; 36 Burtscheidt, Wölwer, Schwarz, Strauss, Gaebel (ref38) 2002; 106 Ponce, Sánchez-García, Rubio, Rodríguez-Jiménez, Jiménez-Arriero, Palomo (ref36) 2005; 33 Nikolakopoulou, Higgins, Papakonstantinou (ref19) 2020; 17 Cornelius, Salloum, Ehler (ref32) 1997; 54 Stella, Addolorato, Rinaldi (ref24) 2008; 57 Lingford-Hughes, Welch, Peters, Nutt (ref58) 2012; 26 Friedmann, Rose, Swift, Stout, Millman, Stein (ref34) 2008; 32 Cheng, Elbers, Higgins (ref10) 2017; 6 Mann, Lehert, Morgan (ref57) 2004; 28 Oslin (ref35) 2005; 13 Chaimani, Higgins, Mavridis, Spyridonos, Salanti (ref22) 2013; 8 Boothby, Doering (ref56) 2005; 27 Coriale, De Rosa, Battagliese (ref41) 2019; 30 Timko, Below, Schultz, Brief, Cucciare (ref59) 2015; 52 Martinotti, Romanelli, Di Nicola, Reina, Mazza, Janiri (ref30) 2007; 16 Miller, Wilbourne (ref9) 2002; 97 Rösner, Hackl-Herrwerth, Leucht, Lehert, Vecchi, Soyka (ref50) 2010 Pelc, Hanak, Baert (ref44) 2005; 40 Papakonstantinou, Nikolakopoulou, Higgins (ref20) 2020; 16 Sekhon, Cartwright, Francis 2017; 17 Burtscheidt, Wölwer, Schwarz, Strauss, Gaebel 2002; 106 Pelc, Hanak, Baert 2005; 40 Timko, Below, Schultz, Brief, Cucciare 2015; 52 Fuller, Branchey, Brightwell 1986; 256 2005; 331 Dawson, Goldstein, Grant 2007; 31 Gustafson, McTavish, Chih 2014; 71 Adamson, Heather, Morton, Raistrick 2010; 45 Lingford-Hughes, Welch, Peters, Nutt 2012; 26 Oslin 2005; 13 1998; 59 Chaimani, Higgins, Mavridis, Spyridonos, Salanti 2013; 8 Salanti, Del Giovane, Chaimani, Caldwell, Higgins 2014; 9 Nikolakopoulou, Higgins, Papakonstantinou 2020; 17 Cornelius, Salloum, Haskett 2000; 25 Liu, Wang, Zhang, Bai, Zhang 2016; 126 Gillam 2008; 336 Friedmann, Rose, Swift, Stout, Millman, Stein 2008; 32 Harrison, Graham, van den Hoek, Dogherty, Carley, Angus 2013; 8 Rösner, Hackl-Herrwerth, Leucht, Lehert, Vecchi, Soyka 2010 Ahmed, Kotapati, Khan 2018; 10 Rösner, Hackl-Herrwerth, Leucht, Vecchi, Srisurapanont, Soyka 2010 Dawson, Grant, Stinson, Chou 2006; 101 Miller, Wilbourne 2002; 97 Dias, Welton, Caldwell, Ades 2010; 29 Williams, Aspinall, Bellis 2014; 384 Palpacuer, Duprez, Huneau 2018; 113 Papakonstantinou, Nikolakopoulou, Higgins 2020; 16 Higgins, Jackson, Barrett, Lu, Ades, White 2012; 3 Ponce, Sánchez-García, Rubio, Rodríguez-Jiménez, Jiménez-Arriero, Palomo 2005; 33 Gual, Lehert 2001; 36 Mann, Lehert, Morgan 2004; 28 Lejoyeux, Lehert 2011; 46 Cornelius, Salloum, Ehler 1997; 54 Jirapramukpitak, Pattanaseri, Chua, Takizawa 2020; 55 Greenhalgh, Peacock 2005; 331 Hutton, Salanti, Caldwell 2015; 162 Sterne, Savović, Page 2019; 366 Cheng, Elbers, Higgins 2017; 6 Stella, Addolorato, Rinaldi 2008; 57 Burtscheidt, Wölwer, Schwarz 2001; 103 Wetzel, Szegedi, Scheurich 2004; 65 Moraes, de Campos, Figlie, Ferraz, Laranjeira 2010; 9 Coriale, De Rosa, Battagliese 2019; 30 Boothby, Doering 2005; 27 Donoghue, Elzerbi, Saunders, Whittington, Pilling, Drummond 2015; 110 Martinotti, Romanelli, Di Nicola, Reina, Mazza, Janiri 2007; 16 Skinner, Lahmek, Pham, Aubin 2014; 9 2020112509201012000_371.nov25_2.m3934.37 2020112509201012000_371.nov25_2.m3934.34 2020112509201012000_371.nov25_2.m3934.35 2020112509201012000_371.nov25_2.m3934.32 2020112509201012000_371.nov25_2.m3934.33 2020112509201012000_371.nov25_2.m3934.30 2020112509201012000_371.nov25_2.m3934.31 2020112509201012000_371.nov25_2.m3934.38 2020112509201012000_371.nov25_2.m3934.39 2020112509201012000_371.nov25_2.m3934.25 2020112509201012000_371.nov25_2.m3934.26 2020112509201012000_371.nov25_2.m3934.23 2020112509201012000_371.nov25_2.m3934.24 2020112509201012000_371.nov25_2.m3934.21 2020112509201012000_371.nov25_2.m3934.22 2020112509201012000_371.nov25_2.m3934.20 2020112509201012000_371.nov25_2.m3934.1 2020112509201012000_371.nov25_2.m3934.2 2020112509201012000_371.nov25_2.m3934.29 2020112509201012000_371.nov25_2.m3934.27 2020112509201012000_371.nov25_2.m3934.28 2020112509201012000_371.nov25_2.m3934.14 2020112509201012000_371.nov25_2.m3934.58 2020112509201012000_371.nov25_2.m3934.15 2020112509201012000_371.nov25_2.m3934.59 2020112509201012000_371.nov25_2.m3934.12 2020112509201012000_371.nov25_2.m3934.56 2020112509201012000_371.nov25_2.m3934.13 2020112509201012000_371.nov25_2.m3934.57 2020112509201012000_371.nov25_2.m3934.10 2020112509201012000_371.nov25_2.m3934.54 2020112509201012000_371.nov25_2.m3934.11 2020112509201012000_371.nov25_2.m3934.55 2020112509201012000_371.nov25_2.m3934.52 2020112509201012000_371.nov25_2.m3934.53 2020112509201012000_371.nov25_2.m3934.18 2020112509201012000_371.nov25_2.m3934.19 2020112509201012000_371.nov25_2.m3934.16 2020112509201012000_371.nov25_2.m3934.17 2020112509201012000_371.nov25_2.m3934.7 2020112509201012000_371.nov25_2.m3934.8 2020112509201012000_371.nov25_2.m3934.9 2020112509201012000_371.nov25_2.m3934.3 2020112509201012000_371.nov25_2.m3934.4 2020112509201012000_371.nov25_2.m3934.5 2020112509201012000_371.nov25_2.m3934.6 2020112509201012000_371.nov25_2.m3934.50 2020112509201012000_371.nov25_2.m3934.51 2020112509201012000_371.nov25_2.m3934.47 2020112509201012000_371.nov25_2.m3934.48 2020112509201012000_371.nov25_2.m3934.45 2020112509201012000_371.nov25_2.m3934.46 2020112509201012000_371.nov25_2.m3934.43 2020112509201012000_371.nov25_2.m3934.44 2020112509201012000_371.nov25_2.m3934.41 2020112509201012000_371.nov25_2.m3934.42 2020112509201012000_371.nov25_2.m3934.49 Ponce (2020112509201012000_371.nov25_2.m3934.36) 2005; 33 2020112509201012000_371.nov25_2.m3934.40 33481761 - BMJ. 2020 Nov 25;371:m4129. doi: 10.1136/bmj.m4129. 33939485 - Ann Intern Med. 2021 May;174(5):JC51. doi: 10.7326/ACPJ202105180-051. 33402357 - BMJ. 2021 Jan 5;372:n5. doi: 10.1136/bmj.n5. |
| References_xml | – volume: 106 start-page: 227 year: 2002 ident: ref38 article-title: Out-patient behaviour therapy in alcoholism: treatment outcome after 2 years publication-title: Acta Psychiatr Scand – volume: 6 start-page: 77 year: 2017 ident: ref10 article-title: Therapeutic interventions for alcohol dependence in non-inpatient settings: a systematic review and network meta-analysis (protocol) publication-title: Syst Rev – volume: 26 start-page: 899 year: 2012 ident: ref58 article-title: BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP publication-title: J Psychopharmacol – volume: 17 start-page: 88 year: 2017 ident: ref52 article-title: Acceptability of healthcare interventions: an overview of reviews and development of a theoretical framework publication-title: BMC Health Serv Res – volume: 366 start-page: l4898 year: 2019 ident: ref18 article-title: RoB 2: a revised tool for assessing risk of bias in randomised trials publication-title: BMJ – volume: 162 start-page: 777 year: 2015 ident: ref11 article-title: The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations publication-title: Ann Intern Med – volume: 8 start-page: 49 year: 2013 ident: ref53 article-title: Guideline adaptation and implementation planning: a prospective observational study publication-title: Implement Sci – volume: 46 start-page: 61 year: 2011 ident: ref55 article-title: Alcohol-use disorders and depression: results from individual patient data meta-analysis of the acamprosate-controlled studies publication-title: Alcohol Alcohol – volume: 27 start-page: 695 year: 2005 ident: ref56 article-title: Acamprosate for the treatment of alcohol dependence publication-title: Clin Ther – volume: 45 start-page: 136 year: 2010 ident: ref13 article-title: Initial preference for drinking goal in the treatment of alcohol problems: II. Treatment outcomes publication-title: Alcohol Alcohol – volume: 126 start-page: 951 year: 2016 ident: ref28 article-title: Epley and Semont maneuvers for posterior canal benign paroxysmal positional vertigo: A network meta-analysis publication-title: Laryngoscope – issue: 12 year: 2010 ident: ref49 article-title: Opioid antagonists for alcohol dependence publication-title: Cochrane Database Syst Rev – volume: 71 start-page: 566 year: 2014 ident: ref37 article-title: A smartphone application to support recovery from alcoholism: a randomized clinical trial publication-title: JAMA Psychiatry – volume: 33 start-page: 13 year: 2005 ident: ref36 article-title: Eficacia de la naltrexona en el tratamiento de mujeres con trastorno por dependencia del alcohol publication-title: Actas Esp Psiquiatr – volume: 256 start-page: 1449 year: 1986 ident: ref23 article-title: Disulfiram treatment of alcoholism. A Veterans Administration cooperative study publication-title: JAMA – volume: 28 start-page: 51 year: 2004 ident: ref17 article-title: The efficacy of acamprosate in the maintenance of abstinence in alcohol-dependent individuals: results of a meta-analysis publication-title: Alcohol Clin Exp Res – volume: 54 start-page: 700 year: 1997 ident: ref32 article-title: Fluoxetine in depressed alcoholics. A double-blind, placebo-controlled trial publication-title: Arch Gen Psychiatry – volume: 384 start-page: 1953 year: 2014 ident: ref2 article-title: Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis publication-title: Lancet – volume: 59 start-page: 631 year: 1998 ident: ref40 article-title: Matching alcoholism treatments to client heterogeneity: treatment main effects and matching effects on drinking during treatment publication-title: J Stud Alcohol – volume: 36 start-page: 413 year: 2001 ident: ref31 article-title: Acamprosate during and after acute alcohol withdrawal: a double-blind placebo-controlled study in Spain publication-title: Alcohol Alcohol – volume: 40 start-page: 302 year: 2005 ident: ref44 article-title: Effect of community nurse follow-up when treating alcohol dependence with acamprosate publication-title: Alcohol Alcohol – volume: 101 start-page: 824 year: 2006 ident: ref5 article-title: Estimating the effect of help-seeking on achieving recovery from alcohol dependence publication-title: Addiction – volume: 97 start-page: 265 year: 2002 ident: ref9 article-title: Mesa Grande: a methodological analysis of clinical trials of treatments for alcohol use disorders publication-title: Addiction – volume: 31 start-page: 2036 year: 2007 ident: ref14 article-title: Rates and correlates of relapse among individuals in remission from DSM-IV alcohol dependence: a 3-year follow-up publication-title: Alcohol Clin Exp Res – volume: 13 start-page: 491 year: 2005 ident: ref35 article-title: Treatment of late-life depression complicated by alcohol dependence publication-title: Am J Geriatr Psychiatry – issue: 9 year: 2010 ident: ref50 article-title: Acamprosate for alcohol dependence publication-title: Cochrane Database Syst Rev – volume: 9 year: 2014 ident: ref51 article-title: Disulfiram efficacy in the treatment of alcohol dependence: a meta-analysis publication-title: PLoS One – volume: 29 start-page: 932 year: 2010 ident: ref27 article-title: Checking consistency in mixed treatment comparison meta-analysis publication-title: Stat Med – volume: 9 year: 2014 ident: ref21 article-title: Evaluating the quality of evidence from a network meta-analysis publication-title: PLoS One – volume: 32 start-page: 1652 year: 2008 ident: ref34 article-title: Trazodone for sleep disturbance after alcohol detoxification: a double-blind, placebo-controlled trial publication-title: Alcohol Clin Exp Res – volume: 336 start-page: 536 year: 2008 ident: ref8 article-title: Is the declaration of Alma Ata still relevant to primary health care? publication-title: BMJ – volume: 17 year: 2020 ident: ref19 article-title: CINeMA: An approach for assessing confidence in the results of a network meta-analysis publication-title: PLoS Med – volume: 331 start-page: 1064 year: 2005 ident: ref15 article-title: Effectiveness and efficiency of search methods in systematic reviews of complex evidence: audit of primary sources publication-title: BMJ – volume: 3 start-page: 98 year: 2012 ident: ref26 article-title: Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies publication-title: Res Synth Methods – volume: 65 start-page: 1406 year: 2004 ident: ref45 article-title: Combination treatment with nefazodone and cognitive-behavioral therapy for relapse prevention in alcohol-dependent men: a randomized controlled study publication-title: J Clin Psychiatry – volume: 10 year: 2018 ident: ref47 article-title: Adding Psychotherapy to the Naltrexone Treatment of Alcohol Use Disorder: Meta-analytic Review publication-title: Cureus – volume: 28 start-page: 51 year: 2004 ident: ref57 article-title: The efficacy of acamprosate in the maintenance of abstinence in alcohol-dependent individuals: results of a meta-analysis publication-title: Alcohol Clin Exp Res – volume: 55 start-page: 171 year: 2020 ident: ref42 article-title: Home-Based Contingency Management Delivered by Community Health Workers to Improve Alcohol Abstinence: A Randomized Control Trial publication-title: Alcohol Alcohol – volume: 57 start-page: 312 year: 2008 ident: ref24 article-title: An open randomized study of the treatment of escitalopram alone and combined with gamma-hydroxybutyric acid and naltrexone in alcoholic patients publication-title: Pharmacol Res – volume: 16 year: 2020 ident: ref20 article-title: CINeMA: Software for semiautomated assessment of the confidence in the results of network meta-analysis publication-title: Campbell Syst Rev – volume: 25 start-page: 307 year: 2000 ident: ref33 article-title: Fluoxetine versus placebo in depressed alcoholics: a 1-year follow-up study publication-title: Addict Behav – volume: 103 start-page: 24 year: 2001 ident: ref39 article-title: Out-patient behaviour therapy in alcoholism: relapse rates after 6 months publication-title: Acta Psychiatr Scand – volume: 16 start-page: 247 year: 2007 ident: ref30 article-title: Oxcarbazepine at high dosages for the treatment of alcohol dependence publication-title: Am J Addict – volume: 331 start-page: 541 year: 2005 ident: ref12 article-title: Effectiveness of treatment for alcohol problems: findings of the randomised UK alcohol treatment trial (UKATT) publication-title: BMJ – volume: 113 start-page: 220 year: 2018 ident: ref46 article-title: Pharmacologically controlled drinking in the treatment of alcohol dependence or alcohol use disorders: a systematic review with direct and network meta-analyses on nalmefene, naltrexone, acamprosate, baclofen and topiramate publication-title: Addiction – volume: 110 start-page: 920 year: 2015 ident: ref48 article-title: The efficacy of acamprosate and naltrexone in the treatment of alcohol dependence, Europe versus the rest of the world: a meta-analysis publication-title: Addiction – volume: 9 start-page: 18 year: 2010 ident: ref43 article-title: Home visits in the outpatient treatment of individuals dependent on alcohol: Randomized clinical trial publication-title: Addict Disord Their Treat – volume: 52 start-page: 31 year: 2015 ident: ref59 article-title: Patient and program factors that bridge the detoxification-treatment gap: a structured evidence review publication-title: J Subst Abuse Treat – volume: 8 year: 2013 ident: ref22 article-title: Graphical tools for network meta-analysis in STATA publication-title: PLoS One – volume: 30 start-page: 125 year: 2019 ident: ref41 article-title: Motivational enhancement therapy versus cognitive behavioral therapy in a cohort of men and women with alcohol use disorder publication-title: Biomedical Reviews – volume: 17 year: 2020 article-title: CINeMA: An approach for assessing confidence in the results of a network meta-analysis publication-title: PLoS Med – volume: 97 start-page: 265 year: 2002 article-title: Mesa Grande: a methodological analysis of clinical trials of treatments for alcohol use disorders publication-title: Addiction – volume: 162 start-page: 777 year: 2015 article-title: The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations publication-title: Ann Intern Med – volume: 46 start-page: 61 year: 2011 article-title: Alcohol-use disorders and depression: results from individual patient data meta-analysis of the acamprosate-controlled studies publication-title: Alcohol Alcohol – volume: 31 start-page: 2036 year: 2007 article-title: Rates and correlates of relapse among individuals in remission from DSM-IV alcohol dependence: a 3-year follow-up publication-title: Alcohol Clin Exp Res – volume: 59 start-page: 631 year: 1998 article-title: Matching alcoholism treatments to client heterogeneity: treatment main effects and matching effects on drinking during treatment publication-title: J Stud Alcohol – volume: 29 start-page: 932 year: 2010 article-title: Checking consistency in mixed treatment comparison meta-analysis publication-title: Stat Med – volume: 26 start-page: 899 year: 2012 article-title: BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP publication-title: J Psychopharmacol – volume: 27 start-page: 695 year: 2005 article-title: Acamprosate for the treatment of alcohol dependence publication-title: Clin Ther – volume: 40 start-page: 302 year: 2005 article-title: Effect of community nurse follow-up when treating alcohol dependence with acamprosate publication-title: Alcohol Alcohol – volume: 16 year: 2020 article-title: CINeMA: Software for semiautomated assessment of the confidence in the results of network meta-analysis publication-title: Campbell Syst Rev – volume: 30 start-page: 125 year: 2019 article-title: Motivational enhancement therapy versus cognitive behavioral therapy in a cohort of men and women with alcohol use disorder publication-title: Biomedical Reviews – volume: 331 start-page: 541 year: 2005 article-title: Effectiveness of treatment for alcohol problems: findings of the randomised UK alcohol treatment trial (UKATT) publication-title: BMJ – volume: 3 start-page: 98 year: 2012 article-title: Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies publication-title: Res Synth Methods – volume: 71 start-page: 566 year: 2014 article-title: A smartphone application to support recovery from alcoholism: a randomized clinical trial publication-title: JAMA Psychiatry – volume: 256 start-page: 1449 year: 1986 article-title: Disulfiram treatment of alcoholism. A Veterans Administration cooperative study publication-title: JAMA – volume: 25 start-page: 307 year: 2000 article-title: Fluoxetine versus placebo in depressed alcoholics: a 1-year follow-up study publication-title: Addict Behav – volume: 366 start-page: l4898 year: 2019 article-title: RoB 2: a revised tool for assessing risk of bias in randomised trials publication-title: BMJ – volume: 110 start-page: 920 year: 2015 article-title: The efficacy of acamprosate and naltrexone in the treatment of alcohol dependence, Europe versus the rest of the world: a meta-analysis publication-title: Addiction – volume: 9 year: 2014 article-title: Evaluating the quality of evidence from a network meta-analysis publication-title: PLoS One – volume: 33 start-page: 13 year: 2005 article-title: Eficacia de la naltrexona en el tratamiento de mujeres con trastorno por dependencia del alcohol publication-title: Actas Esp Psiquiatr – volume: 106 start-page: 227 year: 2002 article-title: Out-patient behaviour therapy in alcoholism: treatment outcome after 2 years publication-title: Acta Psychiatr Scand – volume: 9 year: 2014 article-title: Disulfiram efficacy in the treatment of alcohol dependence: a meta-analysis publication-title: PLoS One – volume: 103 start-page: 24 year: 2001 article-title: Out-patient behaviour therapy in alcoholism: relapse rates after 6 months publication-title: Acta Psychiatr Scand – volume: 52 start-page: 31 year: 2015 article-title: Patient and program factors that bridge the detoxification-treatment gap: a structured evidence review publication-title: J Subst Abuse Treat – issue: 12 year: 2010 article-title: Opioid antagonists for alcohol dependence publication-title: Cochrane Database Syst Rev – volume: 55 start-page: 171 year: 2020 article-title: Home-Based Contingency Management Delivered by Community Health Workers to Improve Alcohol Abstinence: A Randomized Control Trial publication-title: Alcohol Alcohol – volume: 6 start-page: 77 year: 2017 article-title: Therapeutic interventions for alcohol dependence in non-inpatient settings: a systematic review and network meta-analysis (protocol) publication-title: Syst Rev – volume: 8 year: 2013 article-title: Graphical tools for network meta-analysis in STATA publication-title: PLoS One – volume: 36 start-page: 413 year: 2001 article-title: Acamprosate during and after acute alcohol withdrawal: a double-blind placebo-controlled study in Spain publication-title: Alcohol Alcohol – volume: 13 start-page: 491 year: 2005 article-title: Treatment of late-life depression complicated by alcohol dependence publication-title: Am J Geriatr Psychiatry – volume: 32 start-page: 1652 year: 2008 article-title: Trazodone for sleep disturbance after alcohol detoxification: a double-blind, placebo-controlled trial publication-title: Alcohol Clin Exp Res – issue: 9 year: 2010 article-title: Acamprosate for alcohol dependence publication-title: Cochrane Database Syst Rev – volume: 331 start-page: 1064 year: 2005 article-title: Effectiveness and efficiency of search methods in systematic reviews of complex evidence: audit of primary sources publication-title: BMJ – volume: 17 start-page: 88 year: 2017 article-title: Acceptability of healthcare interventions: an overview of reviews and development of a theoretical framework publication-title: BMC Health Serv Res – volume: 126 start-page: 951 year: 2016 article-title: Epley and Semont maneuvers for posterior canal benign paroxysmal positional vertigo: A network meta-analysis publication-title: Laryngoscope – volume: 54 start-page: 700 year: 1997 article-title: Fluoxetine in depressed alcoholics. A double-blind, placebo-controlled trial publication-title: Arch Gen Psychiatry – volume: 16 start-page: 247 year: 2007 article-title: Oxcarbazepine at high dosages for the treatment of alcohol dependence publication-title: Am J Addict – volume: 10 year: 2018 article-title: Adding Psychotherapy to the Naltrexone Treatment of Alcohol Use Disorder: Meta-analytic Review publication-title: Cureus – volume: 8 start-page: 49 year: 2013 article-title: Guideline adaptation and implementation planning: a prospective observational study publication-title: Implement Sci – volume: 336 start-page: 536 year: 2008 article-title: Is the declaration of Alma Ata still relevant to primary health care? publication-title: BMJ – volume: 113 start-page: 220 year: 2018 article-title: Pharmacologically controlled drinking in the treatment of alcohol dependence or alcohol use disorders: a systematic review with direct and network meta-analyses on nalmefene, naltrexone, acamprosate, baclofen and topiramate publication-title: Addiction – volume: 65 start-page: 1406 year: 2004 article-title: Combination treatment with nefazodone and cognitive-behavioral therapy for relapse prevention in alcohol-dependent men: a randomized controlled study publication-title: J Clin Psychiatry – volume: 101 start-page: 824 year: 2006 article-title: Estimating the effect of help-seeking on achieving recovery from alcohol dependence publication-title: Addiction – volume: 9 start-page: 18 year: 2010 article-title: Home visits in the outpatient treatment of individuals dependent on alcohol: Randomized clinical trial publication-title: Addict Disord Their Treat – volume: 384 start-page: 1953 year: 2014 article-title: Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis publication-title: Lancet – volume: 45 start-page: 136 year: 2010 article-title: Initial preference for drinking goal in the treatment of alcohol problems: II. Treatment outcomes publication-title: Alcohol Alcohol – volume: 28 start-page: 51 year: 2004 article-title: The efficacy of acamprosate in the maintenance of abstinence in alcohol-dependent individuals: results of a meta-analysis publication-title: Alcohol Clin Exp Res – volume: 57 start-page: 312 year: 2008 article-title: An open randomized study of the treatment of escitalopram alone and combined with gamma-hydroxybutyric acid and naltrexone in alcoholic patients publication-title: Pharmacol Res – ident: 2020112509201012000_371.nov25_2.m3934.14 doi: 10.1111/j.1530-0277.2007.00536.x – ident: 2020112509201012000_371.nov25_2.m3934.53 doi: 10.1186/1748-5908-8-49 – ident: 2020112509201012000_371.nov25_2.m3934.33 doi: 10.1016/S0306-4603(99)00065-9 – ident: 2020112509201012000_371.nov25_2.m3934.9 doi: 10.1046/j.1360-0443.2002.00019.x – ident: 2020112509201012000_371.nov25_2.m3934.49 doi: 10.1002/14651858.CD001867.pub2 – ident: 2020112509201012000_371.nov25_2.m3934.54 – ident: 2020112509201012000_371.nov25_2.m3934.6 – ident: 2020112509201012000_371.nov25_2.m3934.35 doi: 10.1097/00019442-200506000-00008 – ident: 2020112509201012000_371.nov25_2.m3934.10 doi: 10.1186/s13643-017-0462-2 – ident: 2020112509201012000_371.nov25_2.m3934.21 doi: 10.1371/journal.pone.0099682 – ident: 2020112509201012000_371.nov25_2.m3934.55 doi: 10.1093/alcalc/agq077 – ident: 2020112509201012000_371.nov25_2.m3934.25 – ident: 2020112509201012000_371.nov25_2.m3934.32 doi: 10.1001/archpsyc.1997.01830200024004 – ident: 2020112509201012000_371.nov25_2.m3934.11 doi: 10.7326/M14-2385 – ident: 2020112509201012000_371.nov25_2.m3934.51 doi: 10.1371/journal.pone.0087366 – ident: 2020112509201012000_371.nov25_2.m3934.1 – ident: 2020112509201012000_371.nov25_2.m3934.40 doi: 10.15288/jsa.1998.59.631 – ident: 2020112509201012000_371.nov25_2.m3934.56 doi: 10.1016/j.clinthera.2005.06.015 – ident: 2020112509201012000_371.nov25_2.m3934.26 doi: 10.1002/jrsm.1044 – ident: 2020112509201012000_371.nov25_2.m3934.27 doi: 10.1002/sim.3767 – ident: 2020112509201012000_371.nov25_2.m3934.38 doi: 10.1034/j.1600-0447.2002.02332.x – ident: 2020112509201012000_371.nov25_2.m3934.58 doi: 10.1177/0269881112444324 – ident: 2020112509201012000_371.nov25_2.m3934.24 doi: 10.1016/j.phrs.2008.03.001 – ident: 2020112509201012000_371.nov25_2.m3934.28 doi: 10.1002/lary.25688 – ident: 2020112509201012000_371.nov25_2.m3934.15 doi: 10.1136/bmj.38636.593461.68 – ident: 2020112509201012000_371.nov25_2.m3934.22 doi: 10.1371/journal.pone.0076654 – ident: 2020112509201012000_371.nov25_2.m3934.46 doi: 10.1111/add.13974 – ident: 2020112509201012000_371.nov25_2.m3934.37 doi: 10.1001/jamapsychiatry.2013.4642 – ident: 2020112509201012000_371.nov25_2.m3934.52 doi: 10.1186/s12913-017-2031-8 – ident: 2020112509201012000_371.nov25_2.m3934.17 doi: 10.1097/01.ALC.0000108656.81563.05 – volume: 33 start-page: 13 year: 2005 ident: 2020112509201012000_371.nov25_2.m3934.36 article-title: Eficacia de la naltrexona en el tratamiento de mujeres con trastorno por dependencia del alcohol publication-title: Actas Esp Psiquiatr – ident: 2020112509201012000_371.nov25_2.m3934.34 doi: 10.1111/j.1530-0277.2008.00742.x – ident: 2020112509201012000_371.nov25_2.m3934.4 – ident: 2020112509201012000_371.nov25_2.m3934.41 doi: 10.14748/bmr.v30.6393 – ident: 2020112509201012000_371.nov25_2.m3934.18 doi: 10.1136/bmj.l4898 – ident: 2020112509201012000_371.nov25_2.m3934.39 doi: 10.1111/j.1600-0447.2001.00150.x – ident: 2020112509201012000_371.nov25_2.m3934.8 doi: 10.1136/bmj.39469.432118.AD – ident: 2020112509201012000_371.nov25_2.m3934.23 doi: 10.1001/jama.1986.03380110055026 – ident: 2020112509201012000_371.nov25_2.m3934.44 doi: 10.1093/alcalc/agh136 – ident: 2020112509201012000_371.nov25_2.m3934.59 doi: 10.1016/j.jsat.2014.11.009 – ident: 2020112509201012000_371.nov25_2.m3934.30 doi: 10.1080/10550490701375558 – ident: 2020112509201012000_371.nov25_2.m3934.29 doi: 10.1609/icwsm.v3i1.13937 – ident: 2020112509201012000_371.nov25_2.m3934.50 doi: 10.1002/14651858.CD004332.pub2 – ident: 2020112509201012000_371.nov25_2.m3934.48 doi: 10.1111/add.12875 – ident: 2020112509201012000_371.nov25_2.m3934.3 – ident: 2020112509201012000_371.nov25_2.m3934.43 doi: 10.1097/ADT.0b013e318196d4e5 – ident: 2020112509201012000_371.nov25_2.m3934.16 doi: 10.1007/978-1-4612-2878-3_44 – ident: 2020112509201012000_371.nov25_2.m3934.12 doi: 10.1136/bmj.331.7516.541 – ident: 2020112509201012000_371.nov25_2.m3934.57 doi: 10.1097/01.ALC.0000108656.81563.05 – ident: 2020112509201012000_371.nov25_2.m3934.42 doi: 10.1093/alcalc/agz106 – ident: 2020112509201012000_371.nov25_2.m3934.13 doi: 10.1093/alcalc/agq005 – ident: 2020112509201012000_371.nov25_2.m3934.7 – ident: 2020112509201012000_371.nov25_2.m3934.19 doi: 10.1371/journal.pmed.1003082 – ident: 2020112509201012000_371.nov25_2.m3934.31 doi: 10.1093/alcalc/36.5.413 – ident: 2020112509201012000_371.nov25_2.m3934.2 doi: 10.1016/S0140-6736(14)61838-9 – ident: 2020112509201012000_371.nov25_2.m3934.47 doi: 10.7759/cureus.3107 – ident: 2020112509201012000_371.nov25_2.m3934.5 doi: 10.1111/j.1360-0443.2006.01433.x – ident: 2020112509201012000_371.nov25_2.m3934.45 doi: 10.4088/JCP.v65n1017 – ident: 2020112509201012000_371.nov25_2.m3934.20 doi: 10.1002/cl2.1080 – reference: 33402357 - BMJ. 2021 Jan 5;372:n5. doi: 10.1136/bmj.n5. – reference: 33939485 - Ann Intern Med. 2021 May;174(5):JC51. doi: 10.7326/ACPJ202105180-051. – reference: 33481761 - BMJ. 2020 Nov 25;371:m4129. doi: 10.1136/bmj.m4129. |
| SSID | ssj0002378965 |
| Score | 2.544613 |
| SecondaryResourceType | review_article |
| Snippet | AbstractObjectiveTo determine the most effective interventions in recently detoxified, alcohol dependent patients for implementation in primary... To determine the most effective interventions in recently detoxified, alcohol dependent patients for implementation in primary care. Systematic review and... ObjectiveTo determine the most effective interventions in recently detoxified, alcohol dependent patients for implementation in primary care.DesignSystematic... To determine the most effective interventions in recently detoxified, alcohol dependent patients for implementation in primary care.OBJECTIVETo determine the... |
| SourceID | pubmedcentral proquest pubmed crossref bmj |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | m3934 |
| SubjectTerms | Abstinence Adult Alcohol Alcohol Abstinence - psychology Alcoholism - psychology Alcoholism - therapy Behavior Therapy - methods Bias Clinical medicine Clinical trials Drug withdrawal Drugs Female Humans Intervention Liver diseases Male Meta-analysis Middle Aged Naltrexone Patients Primary care Primary Health Care - methods Randomized Controlled Trials as Topic Systematic review Treatment Outcome |
| Title | Treatment interventions to maintain abstinence from alcohol in primary care: systematic review and network meta-analysis |
| URI | https://bmj.com/content/371/bmj.m3934.full https://www.ncbi.nlm.nih.gov/pubmed/33239318 https://www.proquest.com/docview/2464302625 https://www.proquest.com/docview/2464608049 https://pubmed.ncbi.nlm.nih.gov/PMC7687021 |
| Volume | 371 |
| WOSCitedRecordID | wos000595061600017&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVPQU databaseName: Biological Science Database customDbUrl: eissn: 1756-1833 dateEnd: 20250930 omitProxy: false ssIdentifier: ssj0002378965 issn: 1756-1833 databaseCode: M7P dateStart: 19940108 isFulltext: true titleUrlDefault: http://search.proquest.com/biologicalscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: Health & Medical Collection (ProQuest) customDbUrl: eissn: 1756-1833 dateEnd: 20250930 omitProxy: false ssIdentifier: ssj0002378965 issn: 1756-1833 databaseCode: 7X7 dateStart: 19940108 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: Nursing & Allied Health Database customDbUrl: eissn: 1756-1833 dateEnd: 20250930 omitProxy: false ssIdentifier: ssj0002378965 issn: 1756-1833 databaseCode: 7RV dateStart: 19940108 isFulltext: true titleUrlDefault: https://search.proquest.com/nahs providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1756-1833 dateEnd: 20250930 omitProxy: false ssIdentifier: ssj0002378965 issn: 1756-1833 databaseCode: BENPR dateStart: 19940108 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Research Library customDbUrl: eissn: 1756-1833 dateEnd: 20250930 omitProxy: false ssIdentifier: ssj0002378965 issn: 1756-1833 databaseCode: M2O dateStart: 19940108 isFulltext: true titleUrlDefault: https://search.proquest.com/pqrl providerName: ProQuest – providerCode: PRVPQU databaseName: Science Database (ProQuest) customDbUrl: eissn: 1756-1833 dateEnd: 20250930 omitProxy: false ssIdentifier: ssj0002378965 issn: 1756-1833 databaseCode: M2P dateStart: 19940108 isFulltext: true titleUrlDefault: https://search.proquest.com/sciencejournals providerName: ProQuest |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3Nb9MwFH-iG0K78M0IbJVBHLiY1R-JHS4I0CYOrETTmHqrHMcWRTQda4b48_FL3HSFaRcOsSL7JXH0bL8PP_8ewCsRhJjIraOOKYbeKkG1l5YGbddqJhWX7Tnus89qPNaTSV5Eh9syhlWu1sR2oa4WFn3kB1wG2RkMBp6-O_9JMWsU7q7GFBoD2A6aDcOQrmNe9D4WLpTOszQCCjGRHZTz72_mIsc0yYNwvymM_tEw_w6UvCJ5ju79b5_vw92oc5L33SB5ALdc_RDuHMdd9Ufw-3QVbU5mV0Igl6RZkLkJVeEipgyLQY3rAMEjKcR0uXXDE-S8Q6wgGEX2lqyxoUl3LoaYuiJ1F25O5q4x1EQklMfw9ejw9OMnGjMy0FJmvKGe8VKlqiotHyEwHteZZTbzygY56J021mdGWS90ar31I-lZ5riVSmqjnPHiCWzVi9o9BVIZFRT70ag0zEnOqpKXOigbzkoXLCzHExgGBk3jjFpOW2NFZFOsbDmYwD7ex1-8rv31irdTG_HOMe3Gj-tIX_akN7xvb8Xkda_WHE7gRd8cZihuu5jaLS47miwo5jJPYLcbT_1XhEAIOqYTUBsjrSdA9O_Nlnr2rUUBD3aiCgras5u79Rx2OHoIGKM83YOt5uLS7cNt-6uZLS-GMFAnZ1hOVFvqIWx_OBwXJ0OcSF_assBSFX8A15gpCA |
| linkProvider | ProQuest |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB61BdFeeD8CbTEIpF5C14_EDhJCCKhadbvqYUG9Bcex1UVstu2mLfwpfiPjvLYLVW89cIhk2U5iJ5_HM_b4G4BXHCcxnhgbWiqpX63ioXLChKjtGkWFZKI6x_21LwcDdXCQ7C_A7_YsjHerbGViJajzifFr5JtM4NyJBgOL3h8dhz5qlN9dbUNo1LDYtb_O0WSbvtv5hP_3NWNbn4cft8MmqkCYiZiVoaMsk5HMM8N6ntyNqdhQEztpUJY7q7RxsZbGcRUZZ1xPOBpbZoQUSkurHcfnLsIN4ZnFvKsg2-_WdBiXKomjhsCI8ngzG39_M-aJD8u8iOn5ye8fjfZvx8wLM93Wnf_tG92F241OTT7Ug-AeLNjiPtzaa7wGHsDPYetNT0YXXDynpJyQscYsvIjOUNgVXs4Rf-SG6Dp2MN5BjmpGDuK95N6SGfc1qc_9EF3kpKjd6cnYljrUDdPLQ_hyLf1-BEvFpLBPgORaouHS62WaWsFonrFMoTJljbBoQVoWwDoCIm0kxjStjDEepz6zQkwAaz7ddPGy8o0WS6lp-Nx9WJEfl1V92VW94nmrLahmrZohKoAXXTFKIL-tpAs7Oa3rxGh4iCSAxzV-u7dw7in2qApAziG7q-DZzedLitFhxXKOdrBEBfTp1c16Dsvbw71-2t8Z7D6DFeZXQygNWbQKS-XJqV2Dm-asHE1P1quhSuDbdeP-D83egbw |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB61W1Rx4f0ItMUgkLiEXT8SO0gIAe2KqmW1QgX1FhzHFovYbOmmPP4av45xXtuFqrceOESybCexk8_jGXv8DcBjjpMYT4wNLZXUr1bxUDlhQtR2jaJCMlGd4_64L0cjdXiYjFfgd3sWxrtVtjKxEtT5zPg18j4TOHeiwcCivmvcIsbbw5dH30IfQcrvtLbhNGqI7NlfP9B8m7_Y3cZ__YSx4c7Bm7dhE2EgzETMytBRlslI5plhA0_0xlRsqImdNCjXnVXauFhL47iKjDNuIByNLTNCCqWl1Y7jc1dhTaKSIXqw9npnNH7frfAwLlUSRw2dEeVxP5t-eTbliQ_SvIrp5anwH_32bzfNU_Pe8Or__MWuwZVG2yav6uFxHVZscQPW3zX-BDfh50HrZ08mp5w_56SckanGLLyIzlAMFl4CEn8Yh-g6qjDeQY5qrg7i_eeekwUrNqlPBBFd5KSoHe3J1JY61A0HzC34cCH9vg29YlbYu0ByLdGkGQwyTa1gNM9YplDNskZYtC0tC2ALwZE2smSeVmYaj1OfWaEngE2fbrp4VvnTFlepaZjefcCRr2dVfdRVPed5Gy3AFq1aoCuAh10xyia_4aQLOzup68RokogkgDs1lru3cO7J96gKQC6hvKvgec-XS4rJ54r_HC1kiarpvfOb9QDWEe7p_u5o7z5cZn6ZhNKQRRvQK49P7CZcMt_Lyfx4qxm3BD5dNPD_AHg4i9Y |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Treatment+interventions+to+maintain+abstinence+from+alcohol+in+primary+care%3A+systematic+review+and+network+meta-analysis&rft.jtitle=BMJ+%28Online%29&rft.au=Cheng%2C+Hung-Yuan&rft.au=McGuinness%2C+Luke+A&rft.au=Elbers%2C+Roy+G&rft.au=MacArthur%2C+Georgina+J&rft.date=2020-11-25&rft.eissn=1756-1833&rft.volume=371&rft_id=info:doi/10.1136%2Fbmj.m3934&rft_id=info%3Apmid%2F33239318&rft.externalDBID=BMJ-UK&rft.externalDocID=bmj |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1756-1833&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1756-1833&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1756-1833&client=summon |